13794-28-0 Usage
General Description
ETHYL 2-ISOCYANATOPROPIONATE is a chemical compound with the formula C6H9NO3. It is a clear, colorless liquid with a pungent odor. This chemical is primarily used in the production of various polymers such as polyurethanes and polyamides. It is known to be an irritant to the skin, eyes, and respiratory system, and proper care should be taken when handling it. Additionally, exposure to this compound may cause allergic reactions in some individuals.ETHYL 2-ISOCYANATOPROPIONATE is also considered to be a potential environmental hazard and should be handled and disposed of according to regulations.
Check Digit Verification of cas no
The CAS Registry Mumber 13794-28-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,7,9 and 4 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 13794-28:
(7*1)+(6*3)+(5*7)+(4*9)+(3*4)+(2*2)+(1*8)=120
120 % 10 = 0
So 13794-28-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H9NO3/c1-3-10-6(9)5(2)7-4-8/h5H,3H2,1-2H3
13794-28-0Relevant articles and documents
Tocainide conjugation in humans: novel biotransformation pathway for a primary amine
Elvin,Keenaghan,Byrnes,Tenthorey,McMaster,Takman,Lalka,Manion,Baer,Wolshin,Meyer,Ronfeld
, p. 47 - 49 (1980)
The metabolism of tocainide, an experimental antiarrhythmic drug, was studied in humans. Urinary excretion of unchanged drug was 28-55% in 24 hr after oral dosing. Urine hydrolysis with hydrochloric acid or β-glucuronidase increased tocainide recovery to 55-79%. Saccharo-1,4-lactone inhibited the β-glucuronidase-mediated tocainide recovery increase. Adjustment of urine to pH 13 produced a compound identified as 3-(2,6-xylyl)-5-methylhydantoin. Evidence suggests that it was derived from the same metabolite that formed the additional tocainide after acid or β-glucuronidase treatment. Tocainide carbamoyl O-β-D-glucuronide is the structure proposed for the metabolite. The suggested pathway for its formation involves the addition of carbon dioxide to the amino nitrogen of tocainide followed by uridine diphosphate-glucuronic acid conjugation.
